Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_32502 | 47 | 0.98 | Mlig455_065385 | Neo: - Age: - |
GRIA1 | Mlig455_065385 {REF} {Length: 4211} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.6]; Receptor family ligand binding region [PF01094.30, score=62.0]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=590, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=566, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=590, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=564, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=561, Expect=0.0]} {Dmel: FBgn0038837, CG3822, [Score=479, Expect=2e-155]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=484, Expect=3e-156]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=707, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.101 | 1.427 | 1.00000 | 1.00000 | |
RegionR2 | 1.535 | 1.427 | 0.46329 | 0.85016 | |
RegionR3 | -1.132 | 1.427 | 0.90575 | 1.00000 | |
RegionR4 | 1.043 | 1.427 | 0.42225 | 0.75041 | |
RegionR5 | 0.694 | 1.427 | 0.48375 | 0.84753 | |
RegionR6 | 1.395 | 1.427 | 0.34635 | 0.93194 | |
RegionR7 | -2.608 | 1.427 | 0.99976 | 1.00000 | |
RegionR8 | -2.028 | 1.427 | 0.99967 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -4.113 | 1.427 | 0.99981 | 1.00000 | |
RegenerationR2 | 0.021 | 1.427 | 0.97385 | 1.00000 | |
RegenerationR3 | -0.535 | 1.427 | 0.71105 | 0.95188 | |
RegenerationR4 | -1.489 | 1.427 | 0.30710 | 0.74836 | |
RegenerationR5 | -1.385 | 1.427 | 0.15684 | 0.57818 | |
RegenerationR6 | -1.499 | 1.427 | 0.11746 | 0.42160 | |
RegenerationBL | 0.013 | 1.427 | 0.71055 | 1.00000 | |
RegenerationTP | 1.512 | 1.427 | 0.53731 | 0.92436 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_32502 | 47 | 0.98 | Mlig455_065385 | Neo: - Age: - |
GRIA1 | 5 | - | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_065385 {REF} {Length: 4211} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.6]; Receptor family ligand binding region [PF01094.30, score=62.0]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=590, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=566, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=590, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=564, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=561, Expect=0.0]} {Dmel: FBgn0038837, CG3822, [Score=479, Expect=2e-155]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=484, Expect=3e-156]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=707, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
2. | MligTC455_23098 | 38 | 0.78 | Mlig455_019169 | Neo: - Age: - Region-enriched R2: 6.693/0.03013 |
NR2E3 | 2.678 | - | - | 0.785 | 0.906 | 0.987 | - | Mlig455_019169 {REF} {Length: 2731} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=97.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=85.2]} {Human: ENSG00000278570, NR2E3, nuclear receptor subfamily 2 group E member 3, [RH, Score=220, Expect=3e-64]} {Mouse: ENSMUSG00000032292, Nr2e3, nuclear receptor subfamily 2, group E, member 3, [RH, Score=216, Expect=8e-63]} {Dmel: FBgn0034012, Hr51, Hormone receptor 51, [RH, Score=189, Expect=2e-51]} {Celegans: WBGene00001400, fax-1, Nuclear hormone receptor FAX-1, [RH, Score=179, Expect=1e-49]} {Smed: dd_Smed_v6_24412_0_1, dd_Smed_v6_24412_0_1, [RH, Score=196, Expect=3e-54]} {RNA1310_101745} |
3. | MligTC455_48127 | 47 | 0.97 | Mlig455_037173 | Neo: - Age: - |
2.644 | - | - | 0.708 | 0.955 | 0.981 | - | Mlig455_037173 {REF} {Length: 1938} {RNA1310_42908} {RNA815_22744} | |
4. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
2.597 | - | - | 0.741 | 0.898 | 0.958 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
5. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
2.563 | - | - | 0.736 | 0.843 | 0.984 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
6. | MligTC455_40791 | 75 | 1.56 | Mlig455_013501 | Neo: - Age: - Region-enriched R2: 7.804/0.01222 |
2.562 | - | - | 0.725 | 0.875 | 0.962 | - | Mlig455_013501 {REF} {Length: 2310} {Pfam: WSC domain [PF01822.21, score=57.5]; F5/8 type C domain [PF00754.27, score=52.4]; Clip-domain serine protease homolog Scarface [PF18399.3, score=20.3]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=58.5, Expect=2e-10]} {RNA1509_16751} {RNA1310_14302.1} {RNA815_6113.1} | |
7. | MligTC455_32501 | 34 | 0.71 | Mlig455_053552 | Neo: - Age: - Region-enriched R2: 9.313/0.01306 |
GRIA1 | 2.526 | - | - | 0.706 | 0.828 | 0.992 | - | Mlig455_053552 {REF} {Length: 4329} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.5]; Receptor family ligand binding region [PF01094.30, score=76.3]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=605, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=577, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=577, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=603, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=582, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=576, Expect=0.0]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=499, Expect=6e-161]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=504, Expect=2e-163]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=740, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
8. | MligTC455_17175 | 78 | 1.62 | Mlig455_042330, Mlig455_047110 | Neo: - Age: - |
GABRA6 | 2.519 | - | - | 0.703 | 0.855 | 0.961 | - | Mlig455_042330 {REF} {Length: 1845} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=104.1]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=236, Expect=1e-72]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=229, Expect=4e-69]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=241, Expect=9e-75]} {Dmel: FBgn0030707, CG8916, [Score=248, Expect=4e-77]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=227, Expect=2e-69]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=242, Expect=6e-76]} {RNA1310_60750} {RNA815_41846} Mlig455_047110 {REF} {Length: 1843} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.4]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=248, Expect=4e-76]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=246, Expect=4e-74]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [Score=243, Expect=4e-74]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=242, Expect=1e-73]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=239, Expect=3e-72]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [Score=239, Expect=2e-72]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=236, Expect=2e-71]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=254, Expect=1e-78]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [Score=244, Expect=1e-73]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=244, Expect=1e-74]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [Score=243, Expect=4e-74]} {Dmel: FBgn0030707, CG8916, [Score=268, Expect=2e-83]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=252, Expect=1e-77]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=263, Expect=1e-82]} {RNA1310_60750} {RNA815_41846} |
9. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 2.513 | - | - | 0.735 | 0.802 | 0.976 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
10. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
2.499 | - | - | 0.727 | 0.810 | 0.962 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
11. | MligTC455_41011 | 90 | 1.87 | Mlig455_014030, Mlig455_014036 | Neo: - Age: Down-Up-Down |
2.494 | - | - | 0.755 | 0.757 | 0.982 | - | Mlig455_014030 {REF} {Length: 1659} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.2]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=95.1, Expect=2e-21]} {RNA1310_70554} {RNA815_47734} Mlig455_014036 {REF} {Length: 1980} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=51.3]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.7]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=104, Expect=3e-24]} {RNA1310_70554} {RNA815_47734} |
|
12. | MligTC455_53633 | 1960 | 40.84 | Mlig455_043831, Mlig455_047417, Mlig455_070992 | Neo: - Age: - Region-specific R2: 8.211 Region-enriched R2: 9.874/0.00000 |
2.476 | - | - | 0.716 | 0.792 | 0.968 | - | Mlig455_043831 {REF} {Length: 1456} {RNA1509_16856} {RNA1310_25970.1, RNA1509_16856} {RNA1509_16856, RNA815_11970} Mlig455_047417 {REF} {Length: 1354} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} Mlig455_070992 {REF} {Length: 1455} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} |
|
13. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 2.47 | - | - | 0.769 | 0.749 | 0.952 | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
14. | MligTC455_22212 | 1732 | 36.09 | Mlig455_009239, Mlig455_009645, Mlig455_037058 | Neo: - Age: logFC(26M/2M)=-0.722 Region-specific R2: 6.329 Region-enriched R2: 6.728/0.00000 |
LMNA | 2.432 | - | - | 0.715 | 0.741 | 0.976 | - | Mlig455_009239 {REF} {Length: 2842} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_009645 {REF} {Length: 2337} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_037058 {REF} {Length: 4944} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1310_9741.1, RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1509_18286, RNA1509_31019, RNA1509_37437, RNA815_3167} |
15. | MligTC455_14363 | 57 | 1.18 | Mlig455_014133 | Neo: - Age: - Region-enriched R2: 4.499/0.01811 |
2.418 | - | - | 0.711 | - | 0.965 | 0.742 | Mlig455_014133 {REF} {Length: 323} {NoTransDecoderORF} | |
16. | MligTC455_52507 | 60 | 1.26 | Mlig455_016440 | Neo: - Age: - Region-enriched R2: 5.871/0.01204 |
2.405 | - | - | 0.701 | 0.725 | 0.979 | - | Mlig455_016440 {REF} {Length: 1576} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_98267} | |
17. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
2.396 | - | - | - | 0.721 | 0.973 | 0.702 | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
18. | MligTC455_51238 | 58 | 1.21 | Mlig455_011511 | Neo: - Age: - |
KCNMA1 | 1.915 | - | - | - | 0.944 | 0.971 | - | Mlig455_011511 {REF} {Length: 2300} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.8]; Ion channel [PF07885.18, score=29.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=272, Expect=4e-80]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=271, Expect=4e-79]} {Dmel: FBgn0003429, slo, slowpoke, [Score=180, Expect=8e-48]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=269, Expect=9e-79]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=294, Expect=9e-88]} {RNA1310_5274} {RNA815_44227} |
19. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
1.886 | - | - | - | 0.908 | 0.978 | - | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
20. | MligTC455_32612 | 55 | 1.15 | Mlig455_015630 | Neo: - Age: - Region-enriched R2: 5.626/0.02523 |
ARX | 1.882 | - | - | - | 0.901 | 0.981 | - | Mlig455_015630 {REF} {Length: 2012} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=133, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=118, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=119, Expect=3e-33]} {RNA1310_42333.1} {RNA815_48205} |
21. | MligTC455_48128 | 18 | 0.37 | Mlig455_052326 | Neo: - Age: - |
1.881 | - | - | - | 0.896 | 0.985 | - | Mlig455_052326 {REF} {Length: 3582} {RNA1310_42908} {RNA815_22744} | |
22. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
1.875 | - | - | - | 0.898 | 0.977 | - | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
23. | MligTC455_27332 | 6690 | 139.38 | Mlig455_034839, Mlig455_034841, Mlig455_034842 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.609 Region-specific R2: 8.988 Region-enriched R2: 9.169/0.00000 Regeneration-depleted R2: -8.701 |
1.875 | - | - | - | 0.899 | 0.976 | - | Mlig455_034839 {REF} {Length: 551} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} Mlig455_034841 {REF} {Length: 529} {RNA1509_2874} {RNA1310_102625.1, RNA1509_2874} {RNA1509_2874, RNA815_20834} Mlig455_034842 {REF} {Length: 557} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} |
|
24. | MligTC455_46885 | 72 | 1.49 | Mlig455_015138 | Neo: - Age: - |
PRKG2 | 1.875 | - | - | - | 0.902 | 0.973 | - | Mlig455_015138 {REF} {Length: 3064} {Pfam: Protein kinase domain [PF00069.27, score=227.4]; Cyclic nucleotide-binding domain [PF00027.31, score=128.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=118.5]; Kinase-like [PF14531.8, score=25.1]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=674, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=674, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=682, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=668, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=676, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
25. | MligTC455_47698 | 54 | 1.13 | Mlig455_025417 | Neo: - Age: - |
ADRA2A | 1.872 | - | - | - | 0.909 | 0.963 | - | Mlig455_025417 {REF} {Length: 1772} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=263.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.1]; Olfactory receptor [PF13853.8, score=25.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=267, Expect=3e-85]; ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=258, Expect=4e-82]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=273, Expect=9e-88]} {Dmel: FBgn0038653, CG18208, [Score=222, Expect=3e-66]} {Celegans: WBGene00006411, octr-1, OCTopamine Receptor (GPCR), [Score=272, Expect=2e-88]} {Smed: dd_Smed_v6_48706_0_1, dd_Smed_v6_48706_0_1, [RH, Score=323, Expect=1e-108]} {RNA1310_113575} |
26. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 1.871 | - | - | - | 0.890 | 0.981 | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |
27. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 1.867 | - | - | - | 0.892 | 0.975 | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
28. | MligTC455_49557 | 280 | 5.82 | Mlig455_017273 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.728 Region-specific R2: 3.642 Region-enriched R2: 3.187/0.00196 |
1.866 | - | - | - | 0.893 | 0.973 | - | Mlig455_017273 {REF} {Length: 1333} {RNA1509_52848} {RNA1310_64923, RNA1509_52848} {RNA1509_52848, RNA815_51063} | |
29. | MligTC455_18583 | 12 | 0.24 | Mlig455_045246 | Neo: - Age: - |
1.864 | - | - | - | 0.890 | 0.974 | - | Mlig455_045246 {REF} {Length: 719} | |
30. | MligTC455_52814 | 47 | 0.97 | Mlig455_047356, Mlig455_047365 | Neo: - Age: - |
CNTN2 | 1.863 | - | - | - | 0.891 | 0.972 | - | Mlig455_047356 {REF} {Length: 2537} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.8]; Immunoglobulin domain [PF13927.8, score=52.6]; Immunoglobulin domain [PF13895.8, score=40.4]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=25.9]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=56.6, Expect=8e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.1, Expect=2e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=54.7, Expect=3e-07]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=58.2, Expect=2e-08]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=2e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_18728} Mlig455_047365 {REF} {Length: 3489} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.9]; Immunoglobulin domain [PF13927.8, score=52.8]; Immunoglobulin domain [PF13895.8, score=40.5]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.4]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=55.5, Expect=1e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=53.9, Expect=5e-07]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=53.5, Expect=6e-07]; ENSMUSG00000055022, Cntn1, contactin 1, [Score=52.8, Expect=1e-06]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=1e-06]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=55.5, Expect=1e-07]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=1e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_19521} |
31. | MligTC455_32554 | 51 | 1.07 | Mlig455_024179 | Neo: - Age: - |
1.862 | - | - | - | 0.884 | 0.978 | - | Mlig455_024179 {REF} {Length: 926} {RNA1509_24504} {RNA1310_3168} {RNA815_18309} | |
32. | MligTC455_18384 | 52 | 1.08 | Mlig455_033464, Mlig455_033480 | Neo: - Age: - |
CHRNB3 | 1.856 | - | - | - | 0.879 | 0.977 | - | Mlig455_033464 {REF} {Length: 3273} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=112, Expect=2e-26]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=107, Expect=4e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=102, Expect=2e-23]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=95.5, Expect=5e-21]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=98.2, Expect=5e-22]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=90.5, Expect=1e-19]} {RNA1509_28510} {RNA1310_44183.1} {RNA815_32188} Mlig455_033480 {REF} {Length: 904} {RNA1310_131495} |
33. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 1.855 | - | - | - | 0.877 | 0.978 | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
34. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 1.854 | - | - | - | 0.879 | 0.975 | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
35. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 1.851 | - | - | - | 0.896 | 0.955 | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
36. | MligTC455_44845 | 96 | 2 | Mlig455_063520 | Neo: - Age: - |
LHX5 | 1.851 | - | - | - | 0.876 | 0.975 | - | Mlig455_063520 {REF} {Length: 4042} {Pfam: LIM domain [PF00412.24, score=116.9]; Homeodomain [PF00046.31, score=69.5]; Homeobox KN domain [PF05920.13, score=24.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=19.8]} {Human: ENSG00000089116, LHX5, LIM homeobox 5, [Score=208, Expect=9e-59]; ENSG00000273706, LHX1, LIM homeobox 1, [Score=199, Expect=1e-55]; ENSG00000274577, LHX1, LIM homeobox 1, [Score=199, Expect=1e-55]} {Mouse: ENSMUSG00000029595, Lhx5, LIM homeobox protein 5, [Score=207, Expect=1e-58]; ENSMUSG00000018698, Lhx1, LIM homeobox protein 1, [Score=199, Expect=1e-55]} {Dmel: FBgn0026411, Lim1, LIM homeobox 1, [Score=191, Expect=3e-52]} {Celegans: WBGene00003000, lin-11, [Score=141, Expect=6e-36]} {Smed: dd_Smed_v6_11521_0_1, dd_Smed_v6_11521_0_1, [RH, Score=185, Expect=5e-49]} {RNA1509_55597} {RNA1310_42478} {RNA815_25756} |
37. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
1.851 | - | - | - | 0.896 | 0.955 | - | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
38. | MligTC455_23344 | 17 | 0.36 | Mlig455_014410 | Neo: - Age: - |
1.848 | - | - | - | 0.876 | 0.972 | - | Mlig455_014410 {REF} {Length: 2200} {Pfam: Beta-lactamase [PF00144.26, score=86.5]} {RNA1310_18857} {RNA815_24648} | |
39. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
1.847 | - | - | - | 0.880 | 0.967 | - | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
40. | MligTC455_32575 | 62 | 1.29 | Mlig455_024198 | Neo: - Age: logFC(26M/2M)=-0.353 |
FAT4 | 1.843 | - | - | - | 0.867 | 0.976 | - | Mlig455_024198 {REF} {Length: 7971} {Pfam: Cadherin domain [PF00028.19, score=704.5]; Cadherin-like [PF16184.7, score=77.6]; Cadherin-like [PF08266.14, score=39.5]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=501, Expect=3e-142]; ENSG00000107736, CDH23, cadherin related 23, [Score=498, Expect=1e-141]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=514, Expect=1e-146]; ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=504, Expect=1e-143]} {Dmel: FBgn0284247, ds, dachsous, [Score=457, Expect=3e-129]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=277, Expect=2e-74]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=276, Expect=8e-74]} {RNA1509_24504} {RNA1310_3168, RNA1509_24504} {RNA1509_24504, RNA815_13217} |
41. | MligTC455_46009 | 5464 | 113.82 | Mlig455_061251, Mlig455_062639 | Neo: - Age: logFC(26M/2M)=-0.276 Region-specific R2: 2.871 Region-enriched R2: 2.103/0.00001 |
1.841 | - | - | - | 0.881 | 0.960 | - | Mlig455_061251 {REF} {Length: 1343} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} Mlig455_062639 {REF} {Length: 1176} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} |
|
42. | MligTC455_35124 | 780 | 16.25 | Mlig455_059030, Mlig455_070853 | Neo: - Age: Down-Up-Down Region-enriched R6: 6.026/0.00025 |
1.84 | - | - | - | 0.857 | 0.983 | - | Mlig455_059030 {REF} {Length: 944} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.7]; EF-hand domain pair [PF13499.8, score=25.4]; EF hand [PF00036.34, score=21.8]; EF-hand domain [PF14658.8, score=20.5]; EF-hand domain [PF13405.8, score=19.8]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=128, Expect=6e-38]} {RNA1509_37636} {RNA1310_36928, RNA1509_37636} {RNA1509_37636, RNA815_25288} Mlig455_070853 {REF} {Length: 962} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.8]; EF-hand domain pair [PF13499.8, score=25.6]; EF-hand domain [PF13405.8, score=21.1]; EF hand [PF00036.34, score=21.0]; EF-hand domain [PF14658.8, score=20.2]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=127, Expect=7e-38]} {RNA1509_37636} {RNA1310_36928} {RNA815_25288} |
|
43. | MligTC455_54106 | 87 | 1.81 | Mlig455_046338, Mlig455_068234 | Neo: Int S/G2/M Age: Up-Down-Down |
PLCB1, PLCB3 | 1.837 | - | - | - | 0.859 | 0.978 | - | Mlig455_046338 {REF} {Length: 4577} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.8]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=69.3]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.5]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [Score=797, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [Score=796, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [Score=801, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=418, Expect=4e-125]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=671, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=702, Expect=0.0]} {RNA1509_50989} {RNA1310_17477} {RNA815_25811} Mlig455_068234 {REF} {Length: 4646} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=123.2]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=837, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=831, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=830, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=827, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=444, Expect=7e-134]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=684, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=716, Expect=0.0]} {RNA1509_50989} {RNA1310_17477, RNA1509_50989} {RNA1509_50989, RNA815_25811} |
44. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
1.836 | - | - | - | 0.860 | 0.976 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
45. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 1.83 | - | - | - | 0.856 | 0.974 | - | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
46. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 1.813 | - | - | - | 0.846 | 0.967 | - | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
47. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
1.809 | - | - | - | 0.843 | 0.966 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
48. | MligTC455_15890 | 18 | 0.38 | Mlig455_059636 | Neo: - Age: - |
CD209 | 1.809 | - | - | - | 0.832 | 0.977 | - | Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043} |
49. | MligTC455_53251 | 67 | 1.4 | Mlig455_018510 | Neo: - Age: logFC(26M/2M)=0.877 Region-enriched R2: 4.210/0.03685 |
SYT7 | 1.806 | - | - | - | 0.824 | 0.982 | - | Mlig455_018510 {REF} {Length: 3473} {Pfam: C2 domain [PF00168.32, score=157.9]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=261, Expect=1e-79]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=251, Expect=2e-77]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [Score=233, Expect=6e-74]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=179, Expect=4e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=194, Expect=1e-57]} {RNA1509_49257} {RNA1310_13701} {RNA815_8339} |
50. | MligTC455_17609 | 87 | 1.82 | Mlig455_059630, Mlig455_059644 | Neo: - Age: Up-Down-Down |
GALR2 | 1.805 | - | - | - | 0.834 | 0.971 | - | Mlig455_059630 {REF} {Length: 3780} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} Mlig455_059644 {REF} {Length: 3887} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} |
51. | MligTC455_46982 | 256 | 5.34 | Mlig455_044826 | Neo: - Age: - |
SYN3 | 1.805 | - | - | - | 0.822 | 0.983 | - | Mlig455_044826 {REF} {Length: 2562} {TRANSSPLICED} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=168.9]} {Human: ENSG00000185666, SYN3, synapsin III, [RH, Score=176, Expect=7e-53]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=173, Expect=2e-49]; ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=6e-48]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=186, Expect=1e-54]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=105, Expect=6e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=216, Expect=3e-68]} {RNA1310_32498} {RNA815_34432} |
52. | MligTC455_42493 | 77 | 1.6 | Mlig455_033955 | Neo: - Age: - |
1.803 | - | - | - | 0.837 | 0.966 | - | Mlig455_033955 {REF} {Length: 878} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [RH, Score=75.9, Expect=3e-16]} {RNA1310_57572} | |
53. | MligTC455_32615 | 24 | 0.5 | Mlig455_062450 | Neo: - Age: - |
ARX | 1.802 | - | - | - | 0.834 | 0.968 | - | Mlig455_062450 {REF} {Length: 1977} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=119, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=117, Expect=2e-32]} {RNA1310_53718} {RNA815_48205} |
54. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
1.802 | - | - | - | 0.825 | 0.977 | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
55. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
1.801 | - | - | - | 0.819 | 0.982 | - | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
56. | MligTC455_35044 | 248 | 5.17 | Mlig455_037400 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.538/0.00372 |
1.799 | - | - | - | 0.834 | 0.965 | - | Mlig455_037400 {REF} {Length: 2022} {RNA1509_41763} {RNA1310_23070.1, RNA1509_41763} {RNA1509_41763, RNA815_9632} | |
57. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
1.795 | - | - | - | 0.841 | 0.954 | - | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
58. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
1.794 | - | - | - | 0.835 | 0.959 | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
59. | MligTC455_38065 | 47 | 0.98 | Mlig455_054213 | Neo: - Age: - |
KREMEN2 | 1.793 | - | - | - | 0.809 | 0.984 | - | Mlig455_054213 {REF} {Length: 924} {Pfam: WSC domain [PF01822.21, score=68.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=1e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=52.0, Expect=1e-07]} {RNA1509_53783} {RNA1310_43773} {RNA815_23638} |
60. | MligTC455_45620 | 1952 | 40.67 | Mlig455_002357 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.487/0.00094 Regeneration-depleted BL: -3.636 |
1.792 | - | - | - | 0.842 | 0.950 | - | Mlig455_002357 {REF} {Length: 933} {RNA1509_8166} {RNA1310_46295} {RNA815_23543} | |
61. | MligTC455_50861 | 422 | 8.78 | Mlig455_050457 | Neo: - Age: Down-Up-Down Region-enriched R2: 2.760/0.00000 |
CPLX2 | 1.787 | - | - | - | 0.819 | 0.968 | - | Mlig455_050457 {REF} {Length: 2902} {Pfam: Synaphin protein [PF05835.14, score=85.3]} {Human: ENSG00000145920, CPLX2, complexin 2, [RH, Score=55.1, Expect=1e-10]} {Mouse: ENSMUSG00000025867, Cplx2, complexin 2, [RH, Score=50.8, Expect=1e-08]} {Dmel: FBgn0041605, cpx, complexin, [Score=64.3, Expect=7e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=71.2, Expect=1e-16]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=78.6, Expect=1e-19]} {RNA1509_56433} {RNA1310_16525, RNA1509_56433} {RNA1509_56433, RNA815_8066.1} |
62. | MligTC455_46543 | 178 | 3.7 | Mlig455_000344, Mlig455_067946 | Neo: - Age: - Region-specific R2: 6.098 Region-enriched R2: 6.851/0.00000 |
1.784 | - | - | - | 0.805 | 0.979 | - | Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120} Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435} |
|
63. | MligTC455_39518 | 40 | 0.83 | Mlig455_031401 | Neo: - Age: - |
CHRNA1 | 1.779 | - | - | - | 0.956 | - | 0.823 | Mlig455_031401 {REF} {Length: 2411} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=92.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=76.4]} {Human: ENSG00000138435, CHRNA1, cholinergic receptor nicotinic alpha 1 subunit, [Score=120, Expect=3e-29]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=120, Expect=2e-29]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=115, Expect=2e-27]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=114, Expect=3e-27]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=134, Expect=2e-34]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=135, Expect=1e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=124, Expect=5e-31]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=114, Expect=2e-27]} {RNA1509_53098} {RNA1310_67430} {RNA815_23438} |
64. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 1.777 | - | - | - | 0.826 | 0.951 | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
65. | MligTC455_20028 | 492 | 10.25 | Mlig455_060293, Mlig455_065638 | Neo: - Age: logFC(26M/2M)=-0.541 Region-enriched R2: 1.959/0.01794 |
LRRC55 | 1.777 | - | - | - | 0.814 | 0.963 | - | Mlig455_060293 {REF} {Length: 2403} {Pfam: Leucine rich repeat [PF13855.8, score=64.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.3]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=59.7, Expect=4e-09]; ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=58.5, Expect=6e-09]; ENSMUSG00000020105, Lrig3, leucine-rich repeats and immunoglobulin-like domains 3, [Score=57.0, Expect=4e-08]} {Dmel: FBgn0033250, CG14762, [Score=63.2, Expect=2e-10]} {RNA1509_43260} {RNA1310_15302, RNA1509_43260} {RNA1509_43260, RNA815_13279} Mlig455_065638 {REF} {Length: 2056} {Pfam: Leucine rich repeat [PF13855.8, score=62.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.6]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=61.2, Expect=1e-09]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=60.1, Expect=2e-09]} {Dmel: FBgn0033250, CG14762, [Score=62.4, Expect=5e-10]} {RNA1509_43260} {RNA1310_15302} {RNA815_13279} |
66. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 1.777 | - | - | - | 0.820 | 0.957 | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
67. | MligTC455_51881 | 14 | 0.3 | Mlig455_047149, Mlig455_047294 | Neo: - Age: - |
CHAC1 | 1.773 | - | - | - | - | 0.977 | 0.796 | Mlig455_047149 {REF} {Length: 1045} {Pfam: ChaC-like protein [PF04752.14, score=137.0]} {Human: ENSG00000128965, CHAC1, ChaC glutathione specific gamma-glutamylcyclotransferase 1, [Score=134, Expect=5e-39]} {Mouse: ENSMUSG00000027313, Chac1, ChaC, cation transport regulator 1, [Score=133, Expect=1e-38]} {Dmel: FBgn0039109, CG10365, [Score=112, Expect=5e-30]} {Celegans: WBGene00017724, F22F7.7, Gamma-glutamylcyclotransferase, [Score=108, Expect=9e-30]} {Smed: dd_Smed_v6_2439_0_1, dd_Smed_v6_2439_0_1, [Score=155, Expect=1e-47]} {RNA1310_83351} Mlig455_047294 {REF} {Length: 1073} {Pfam: ChaC-like protein [PF04752.14, score=166.0]} {Human: ENSG00000128965, CHAC1, ChaC glutathione specific gamma-glutamylcyclotransferase 1, [RH, Score=153, Expect=6e-46]} {Mouse: ENSMUSG00000027313, Chac1, ChaC, cation transport regulator 1, [RH, Score=150, Expect=6e-45]} {Dmel: FBgn0039109, CG10365, [Score=131, Expect=5e-37]} {Celegans: WBGene00017724, F22F7.7, Gamma-glutamylcyclotransferase, [RH, Score=126, Expect=9e-36]} {Smed: dd_Smed_v6_2439_0_1, dd_Smed_v6_2439_0_1, [Score=182, Expect=2e-57]} {RNA1310_83351} |
68. | MligTC455_23825 | 29 | 0.6 | Mlig455_002166, Mlig455_002310 | Neo: - Age: Down-Up-Down |
NOL4 | 1.771 | - | - | - | 0.794 | 0.977 | - | Mlig455_002166 {REF} {Length: 3243} {Human: ENSG00000101746, NOL4, nucleolar protein 4, [RH, Score=135, Expect=9e-35]} {Mouse: ENSMUSG00000041923, Nol4, nucleolar protein 4, [RH, Score=136, Expect=1e-34]} {Dmel: FBgn0283651, CG46301, [RH, Score=140, Expect=4e-35]} {Smed: dd_Smed_v6_10255_0_1, dd_Smed_v6_10255_0_1, [RH, Score=82.4, Expect=6e-17]} {RNA1509_41791} {RNA1310_36173.1} {RNA815_37287} Mlig455_002310 {REF} {Length: 2667} {Human: ENSG00000101746, NOL4, nucleolar protein 4, [RH, Score=135, Expect=1e-34]} {Mouse: ENSMUSG00000041923, Nol4, nucleolar protein 4, [RH, Score=136, Expect=1e-34]} {Dmel: FBgn0283651, CG46301, [RH, Score=140, Expect=4e-35]} {Smed: dd_Smed_v6_10255_0_1, dd_Smed_v6_10255_0_1, [RH, Score=82.4, Expect=6e-17]} {RNA1509_41791} {RNA1310_36173.1} |
69. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
1.771 | - | - | - | 0.812 | 0.959 | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
70. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
1.768 | - | - | 0.791 | - | 0.977 | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
71. | MligTC455_44861 | 2493 | 51.93 | Mlig455_012204, Mlig455_069065 | Neo: - Age: - Region-specific R2: 2.926 Region-enriched R2: 2.403/0.00000 Regeneration-downregulated BL: -1.850 Regeneration-depleted BL: -1.850 |
QPCT | 1.767 | - | - | - | 0.811 | 0.956 | - | Mlig455_012204 {REF} {Length: 1746} {Pfam: Peptidase family M28 [PF04389.19, score=139.1]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [RH, Score=186, Expect=7e-56]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [RH, Score=181, Expect=2e-53]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [RH, Score=184, Expect=6e-55]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [RH, Score=184, Expect=2e-55]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [RH, Score=208, Expect=8e-65]} {Celegans: WBGene00010418, H27A22.1, [Score=183, Expect=2e-55]} {Smed: dd_Smed_v6_4861_0_2, dd_Smed_v6_4861_0_2, [Score=162, Expect=3e-47]} {RNA1509_15042} {RNA1310_21925} {RNA815_8635.2} Mlig455_069065 {REF} {Length: 1718} {Pfam: Peptidase family M28 [PF04389.19, score=83.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=133, Expect=1e-36]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [Score=128, Expect=1e-34]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=138, Expect=1e-38]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=135, Expect=2e-37]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [Score=157, Expect=3e-46]} {Celegans: WBGene00010418, H27A22.1, [Score=148, Expect=9e-43]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=119, Expect=8e-32]} {RNA1509_15042} {RNA1310_21925} {RNA815_8635.2} |
72. | MligTC455_44904 | 1501 | 31.27 | Mlig455_021814 | Neo: - Age: Down-Up-Up Region-specific R2: 3.865 Region-enriched R2: 3.792/0.00000 |
1.767 | - | - | - | 0.811 | 0.956 | - | Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533} | |
73. | MligTC455_13866 | 60 | 1.26 | Mlig455_059198 | Neo: - Age: - |
1.762 | - | - | - | 0.796 | 0.966 | - | Mlig455_059198 {REF} {Length: 561} {NoTransDecoderORF} {RNA1310_89423} {RNA815_50610} | |
74. | MligTC455_19423 | 11 | 0.23 | Mlig455_012243, Mlig455_012256 | Neo: - Age: - |
1.759 | - | - | - | - | 0.978 | 0.781 | Mlig455_012243 {REF} {Length: 702} {NoTransDecoderORF} {RNA1310_51059.1} {RNA815_47115} Mlig455_012256 {REF} {Length: 832} {NoTransDecoderORF} {RNA1310_51059.1} {RNA815_38253.1} |
|
75. | MligTC455_46467 | 4047 | 84.32 | Mlig455_009033 | Neo: - Age: Down-Up-Down Region-specific R2: 2.894 Region-enriched R2: 2.264/0.00006 Regeneration-downregulated BL: -2.309 Regeneration-depleted BL: -2.309 |
1.759 | - | - | - | 0.801 | 0.958 | - | Mlig455_009033 {REF} {Length: 1015} {RNA1509_10834, RNA1509_4025, RNA1509_9692} {RNA1310_57568, RNA1509_10834, RNA1509_4025, RNA1509_9692} {RNA1509_10834, RNA1509_4025, RNA1509_9692, RNA815_29793} | |
76. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
1.758 | - | - | - | 0.778 | 0.980 | - | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
77. | MligTC455_28903 | 55 | 1.14 | Mlig455_030222, Mlig455_067999 | Neo: - Age: Up-Down-Down |
FAT4 | 1.758 | - | - | - | 0.804 | 0.954 | - | Mlig455_030222 {REF} {Length: 8676} {Pfam: Cadherin domain [PF00028.19, score=744.0]; Cadherin-like [PF16184.7, score=94.9]; Cadherin-like [PF08266.14, score=40.7]; RET Cadherin like domain 1 [PF17756.3, score=23.4]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=518, Expect=1e-147]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=9e-152]} {Dmel: FBgn0001075, ft, fat, [Score=479, Expect=9e-136]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=260, Expect=4e-69]} {RNA1509_58830} {RNA1310_15141, RNA1509_58830} {RNA1509_58830, RNA815_18357} Mlig455_067999 {REF} {Length: 8147} {Pfam: Cadherin domain [PF00028.19, score=745.9]; Cadherin-like [PF16184.7, score=94.8]; Cadherin-like [PF08266.14, score=40.9]; RET Cadherin like domain 1 [PF17756.3, score=23.3]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=519, Expect=6e-148]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=531, Expect=7e-152]} {Dmel: FBgn0001075, ft, fat, [Score=476, Expect=8e-135]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=268, Expect=1e-71]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=261, Expect=2e-69]} {RNA1509_58830} {RNA1310_15141} {RNA815_18357} |
78. | MligTC455_37627 | 238 | 4.95 | Mlig455_054399, Mlig455_054423 | Neo: - Age: - |
DPP6 | 1.758 | - | - | - | 0.783 | 0.975 | - | Mlig455_054399 {REF} {Length: 2976} {Pfam: Dipeptidyl peptidase IV (DPP IV) N-terminal region [PF00930.23, score=233.7]; Prolyl oligopeptidase family [PF00326.23, score=140.9]; Dienelactone hydrolase family [PF01738.20, score=23.6]; Alpha/beta hydrolase family [PF12697.9, score=22.7]} {Human: ENSG00000282974, DPP6, dipeptidyl peptidase like 6, [RH, Score=350, Expect=6e-107]; ENSG00000130226, DPP6, dipeptidyl peptidase like 6, [RH, Score=350, Expect=6e-107]} {Mouse: ENSMUSG00000061576, Dpp6, dipeptidylpeptidase 6, [RH, Score=347, Expect=3e-105]} {Dmel: FBgn0031741, CG11034, [RH, Score=289, Expect=3e-85]} {Celegans: WBGene00001054, dpf-1, Dipeptidyl peptidase family member 1, [RH, Score=244, Expect=1e-68]} {Smed: dd_Smed_v6_9183_0_1, dd_Smed_v6_9183_0_1, [RH, Score=462, Expect=1e-149]} {RNA1310_6490.1} {RNA815_13029} Mlig455_054423 {REF} {Length: 3076} {Pfam: Dipeptidyl peptidase IV (DPP IV) N-terminal region [PF00930.23, score=232.4]; Prolyl oligopeptidase family [PF00326.23, score=141.3]; Dienelactone hydrolase family [PF01738.20, score=23.7]; Alpha/beta hydrolase family [PF12697.9, score=22.9]} {Human: ENSG00000282974, DPP6, dipeptidyl peptidase like 6, [RH, Score=344, Expect=7e-105]; ENSG00000130226, DPP6, dipeptidyl peptidase like 6, [RH, Score=344, Expect=7e-105]} {Mouse: ENSMUSG00000061576, Dpp6, dipeptidylpeptidase 6, [RH, Score=338, Expect=6e-103]} {Dmel: FBgn0031741, CG11034, [RH, Score=291, Expect=3e-86]} {Celegans: WBGene00001054, dpf-1, Dipeptidyl peptidase family member 1, [RH, Score=248, Expect=2e-70]} {Smed: dd_Smed_v6_9183_0_1, dd_Smed_v6_9183_0_1, [RH, Score=464, Expect=8e-151]} {RNA1310_6490.1} {RNA815_13029} |
79. | MligTC455_34518 | 327 | 6.81 | Mlig455_049366, Mlig455_062300 | Neo: - Age: - Region-enriched R2: 6.673/0.00158 |
DMRTA2 | 1.756 | - | - | - | 0.780 | 0.976 | - | Mlig455_049366 {REF} {Length: 1964} {Pfam: DM DNA binding domain [PF00751.20, score=82.7]; DMRTA motif [PF03474.16, score=39.9]} {Human: ENSG00000142700, DMRTA2, DMRT like family A2, [RH, Score=155, Expect=4e-41]} {Mouse: ENSMUSG00000047143, Dmrta2, doublesex and mab-3 related transcription factor like family A2, [RH, Score=154, Expect=1e-40]} {Dmel: FBgn0039683, dmrt99B, doublesex-Mab related 99B, [RH, Score=159, Expect=1e-42]} {Celegans: WBGene00017326, dmd-5, DM (Doublesex/MAB-3) Domain family, [RH, Score=139, Expect=7e-38]} {Smed: dd_Smed_v6_31674_0_1, dd_Smed_v6_31674_0_1, [RH, Score=137, Expect=9e-38]} {RNA1310_36206} {RNA815_36280} Mlig455_062300 {REF} {Length: 2056} {Pfam: DM DNA binding domain [PF00751.20, score=82.7]; DMRTA motif [PF03474.16, score=39.9]} {Human: ENSG00000142700, DMRTA2, DMRT like family A2, [RH, Score=155, Expect=4e-41]} {Mouse: ENSMUSG00000047143, Dmrta2, doublesex and mab-3 related transcription factor like family A2, [RH, Score=154, Expect=1e-40]} {Dmel: FBgn0039683, dmrt99B, doublesex-Mab related 99B, [RH, Score=159, Expect=1e-42]} {Celegans: WBGene00017326, dmd-5, DM (Doublesex/MAB-3) Domain family, [RH, Score=139, Expect=8e-38]} {Smed: dd_Smed_v6_31674_0_1, dd_Smed_v6_31674_0_1, [RH, Score=137, Expect=8e-38]} {RNA1310_36206} {RNA815_36280} |
80. | MligTC455_38780 | 235 | 4.89 | Mlig455_000360, Mlig455_056487 | Neo: - Age: - Region-enriched R2: 3.921/0.00457 |
SGSM1 | 1.755 | - | - | - | 0.796 | 0.959 | - | Mlig455_000360 {REF} {Length: 3015} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=53.6]; RUN domain [PF02759.21, score=45.8]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=170, Expect=8e-43]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=165, Expect=2e-41]} {Dmel: FBgn0052506, CG32506, [Score=150, Expect=1e-36]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=184, Expect=7e-48]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=196, Expect=1e-51]} {RNA1310_67163} {RNA815_24450} Mlig455_056487 {REF} {Length: 3063} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=52.8]; RUN domain [PF02759.21, score=45.7]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=171, Expect=6e-43]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=166, Expect=2e-41]} {Dmel: FBgn0052506, CG32506, [Score=150, Expect=9e-37]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=183, Expect=2e-47]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=193, Expect=2e-50]} {RNA1310_67163} {RNA815_24450} |
81. | MligTC455_49123 | 58 | 1.21 | Mlig455_057651 | Neo: - Age: - |
ASIC1 | 1.754 | - | - | - | 0.780 | 0.974 | - | Mlig455_057651 {REF} {Length: 2608} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=188.4]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=71.2, Expect=3e-12]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=67.0, Expect=4e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=89.0, Expect=3e-18]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=65.9, Expect=4e-11]} {RNA1310_10141} {RNA815_10820} |
82. | MligTC455_15215 | 22 | 0.46 | Mlig455_037928 | Neo: - Age: - |
CHRNA9 | 1.753 | - | - | - | 0.770 | 0.983 | - | Mlig455_037928 {REF} {Length: 2079} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=180.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=57.1]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=221, Expect=7e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=9e-64]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=222, Expect=1e-65]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=219, Expect=3e-64]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=214, Expect=7e-63]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=228, Expect=2e-65]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=221, Expect=6e-65]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=1e-62]} {RNA1310_88831} |
83. | MligTC455_20730 | 43 | 0.9 | Mlig455_050491, Mlig455_050492 | Neo: - Age: - |
GABBR2 | 1.75 | - | - | 0.760 | - | 0.990 | - | Mlig455_050491 {REF} {Length: 2570} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=128.2]; Receptor family ligand binding region [PF01094.30, score=119.0]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=236, Expect=1e-65]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=234, Expect=4e-65]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=250, Expect=3e-70]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=206, Expect=4e-56]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=108, Expect=2e-26]} {RNA1310_11554} {RNA815_30781} Mlig455_050492 {REF} {Length: 3107} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=130.0]; Receptor family ligand binding region [PF01094.30, score=118.1]; Phage integrase family [PF00589.24, score=28.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=233, Expect=2e-63]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=233, Expect=1e-63]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=258, Expect=2e-71]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=210, Expect=2e-56]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=118, Expect=1e-29]} {RNA1310_11554} {RNA815_30781} |
84. | MligTC455_08333 | 172 | 3.59 | Mlig455_025435, Mlig455_025445 | Neo: - Age: - |
TNS1 | 1.749 | - | - | - | 0.788 | 0.961 | - | Mlig455_025435 {REF} {Length: 4797} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=67.1]; C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=38.4]; SH2 domain [PF00017.26, score=36.5]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=257, Expect=2e-69]; ENSG00000136205, TNS3, tensin 3, [RH, Score=251, Expect=1e-67]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [RH, Score=256, Expect=1e-72]; ENSMUSG00000020422, Tns3, tensin 3, [RH, Score=251, Expect=1e-67]} {Dmel: FBgn0000244, by, blistery, [RH, Score=222, Expect=2e-60]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=243, Expect=6e-72]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=217, Expect=5e-59]} {RNA1509_43365} {RNA1310_7714, RNA1509_43365} {RNA1509_43365, RNA815_14514} Mlig455_025445 {REF} {Length: 1758} {Pfam: C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=37.0]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=191, Expect=2e-53]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=191, Expect=3e-51]; ENSMUSG00000037003, Tns2, tensin 2, [Score=187, Expect=4e-50]} {Dmel: FBgn0026379, Pten, Phosphatase and tensin homolog, [Score=67.8, Expect=1e-11]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=109, Expect=1e-24]} {RNA1509_44169} {RNA1310_10509} {RNA815_24170} |
85. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
1.747 | - | - | - | 0.773 | 0.974 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
86. | MligTC455_27330 | 2939 | 61.23 | Mlig455_029694 | Neo: - Age: - Region-specific R2: 5.698 Region-enriched R2: 5.201/0.00000 Regeneration-downregulated R2: -3.996 Regeneration-depleted R2: -3.996 |
1.746 | - | - | - | 0.773 | 0.973 | - | Mlig455_029694 {REF} {Length: 2374} {TRANSSPLICED} {RNA1509_22512} {RNA1310_16498, RNA1509_22512} {RNA1509_22512, RNA815_17345} | |
87. | MligTC455_48428 | 578 | 12.04 | Mlig455_034987, Mlig455_053697, Mlig455_064889 | Neo: - Age: - |
NEO1 | 1.736 | - | - | - | 0.777 | 0.959 | - | Mlig455_034987 {REF} {Length: 1449} {Pfam: Immunoglobulin domain [PF13927.8, score=83.0]; Immunoglobulin I-set domain [PF07679.18, score=69.9]; Immunoglobulin domain [PF13895.8, score=59.6]; Immunoglobulin domain [PF00047.27, score=52.1]; Immunoglobulin V-set domain [PF07686.19, score=43.6]; Immunoglobulin domain [PF18452.3, score=26.9]} {Human: ENSG00000067141, NEO1, neogenin 1, [Score=102, Expect=1e-22]; ENSG00000166450, PRTG, protogenin, [Score=97.8, Expect=3e-21]} {Mouse: ENSMUSG00000036030, Prtg, protogenin, [Score=94.4, Expect=3e-20]} {Dmel: FBgn0011592, fra, frazzled, [Score=76.6, Expect=1e-14]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_11123_0_1, dd_Smed_v6_11123_0_1, [Score=59.7, Expect=2e-09]} {RNA1509_18708} {RNA1310_41845} {RNA815_22774} Mlig455_053697 {REF} {Length: 5168} {Pfam: Fibronectin type III domain [PF00041.23, score=164.7]; Immunoglobulin domain [PF13927.8, score=111.6]; Immunoglobulin I-set domain [PF07679.18, score=105.0]; Immunoglobulin domain [PF13895.8, score=85.3]; Immunoglobulin domain [PF00047.27, score=61.8]; Immunoglobulin V-set domain [PF07686.19, score=50.1]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=41.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.3]; Immunoglobulin domain [PF18452.3, score=25.2]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=313, Expect=1e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=298, Expect=8e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=242, Expect=2e-64]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=82.8, Expect=2e-15]} {Smed: dd_Smed_v6_11409_0_1, dd_Smed_v6_11409_0_1, [RH, Score=114, Expect=2e-25]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774} Mlig455_064889 {REF} {Length: 4838} {Pfam: Fibronectin type III domain [PF00041.23, score=167.9]; Immunoglobulin domain [PF13927.8, score=111.8]; Immunoglobulin I-set domain [PF07679.18, score=105.5]; Immunoglobulin domain [PF13895.8, score=85.9]; Immunoglobulin domain [PF00047.27, score=60.6]; Immunoglobulin V-set domain [PF07686.19, score=50.4]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=42.6]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.5]; Immunoglobulin domain [PF18452.3, score=25.3]; Neuron-derived neurotrophic factor [PF10179.11, score=20.3]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=311, Expect=5e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=300, Expect=2e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=239, Expect=1e-63]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=81.6, Expect=4e-15]} {Smed: dd_Smed_v6_7195_0_1, dd_Smed_v6_7195_0_1, [Score=111, Expect=2e-24]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774} |
88. | MligTC455_29516 | 38 | 0.8 | Mlig455_029373 | Neo: - Age: Up-Down-Up |
GRIA2 | 1.734 | - | - | - | 0.760 | 0.974 | - | Mlig455_029373 {REF} {Length: 3044} {Pfam: Ligand-gated ion channel [PF00060.28, score=103.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=63.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=23.4]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=158, Expect=3e-39]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=158, Expect=3e-39]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=157, Expect=5e-39]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=155, Expect=2e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=155, Expect=3e-38]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=154, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=153, Expect=1e-37]} {Mouse: ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=159, Expect=2e-39]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=158, Expect=2e-39]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=155, Expect=2e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=155, Expect=1e-38]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=153, Expect=1e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=152, Expect=1e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=152, Expect=3e-37]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=152, Expect=3e-37]} {Dmel: FBgn0038837, CG3822, [Score=151, Expect=3e-37]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=139, Expect=1e-33]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=241, Expect=1e-71]} {RNA1310_63010} {RNA815_33834} |
89. | MligTC455_33848 | 177 | 3.7 | Mlig455_000010, Mlig455_000046 | Neo: - Age: logFC(26M/2M)=-0.353 |
GRIA2 | 1.73 | - | - | - | 0.758 | 0.972 | - | Mlig455_000010 {REF} {Length: 3793} {Pfam: Ligand-gated ion channel [PF00060.28, score=148.7]; Receptor family ligand binding region [PF01094.30, score=103.6]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=41.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=22.2]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=462, Expect=2e-146]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=456, Expect=1e-143]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=453, Expect=9e-143]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=449, Expect=2e-141]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=459, Expect=1e-145]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=457, Expect=2e-144]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=457, Expect=2e-144]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=449, Expect=1e-141]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [Score=399, Expect=1e-121]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=328, Expect=3e-96]} {Smed: dd_Smed_v6_19602_0_1, dd_Smed_v6_19602_0_1, [Score=522, Expect=4e-169]} {RNA1509_28586} {RNA1310_3529} {RNA815_7464} Mlig455_000046 {REF} {Length: 3946} {Pfam: Ligand-gated ion channel [PF00060.28, score=148.4]; Receptor family ligand binding region [PF01094.30, score=125.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=83.5]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=561, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=550, Expect=2e-179]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [RH, Score=545, Expect=2e-177]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=557, Expect=0.0]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [RH, Score=545, Expect=9e-178]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=521, Expect=2e-167]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [RH, Score=390, Expect=4e-119]} {Smed: dd_Smed_v6_19602_0_1, dd_Smed_v6_19602_0_1, [RH, Score=681, Expect=0.0]} {RNA1509_28586} {RNA1310_3529} {RNA815_7464} |
90. | MligTC455_21258 | 64 | 1.34 | Mlig455_001143, Mlig455_001305 | Neo: - Age: - |
FOXD4 | 1.729 | - | - | - | 0.776 | 0.953 | - | Mlig455_001143 {REF} {Length: 2344} {Pfam: Forkhead domain [PF00250.20, score=125.5]} {Human: ENSG00000170122, FOXD4, forkhead box D4, [RH, Score=197, Expect=1e-57]; ENSG00000187140, FOXD3, forkhead box D3, [RH, Score=196, Expect=6e-57]} {Mouse: ENSMUSG00000067261, Foxd3, forkhead box D3, [RH, Score=197, Expect=2e-57]; ENSMUSG00000116152, Foxd3, forkhead box D3, [RH, Score=197, Expect=2e-57]} {Dmel: FBgn0004896, fd59A, forkhead domain 59A, [RH, Score=210, Expect=8e-63]} {Celegans: WBGene00006853, unc-130, [RH, Score=207, Expect=4e-63]} {Smed: dd_Smed_v6_23249_0_1, dd_Smed_v6_23249_0_1, [RH, Score=223, Expect=2e-68]} {RNA1310_116948} Mlig455_001305 {REF} {Length: 1757} {Pfam: Forkhead domain [PF00250.20, score=51.7]} {Human: ENSG00000170122, FOXD4, forkhead box D4, [Score=99.4, Expect=3e-22]; ENSG00000187140, FOXD3, forkhead box D3, [Score=96.3, Expect=5e-21]} {Mouse: ENSMUSG00000116152, Foxd3, forkhead box D3, [Score=96.7, Expect=2e-21]; ENSMUSG00000067261, Foxd3, forkhead box D3, [Score=96.7, Expect=2e-21]} {Dmel: FBgn0004896, fd59A, forkhead domain 59A, [Score=112, Expect=6e-27]} {Celegans: WBGene00006853, unc-130, [Score=115, Expect=7e-29]} {Smed: dd_Smed_v6_23249_0_1, dd_Smed_v6_23249_0_1, [Score=124, Expect=2e-31]} {RNA1310_116948} |
91. | MligTC455_52310 | 100 | 2.08 | Mlig455_014082 | Neo: - Age: - Region-enriched R2: 4.038/0.02037 |
1.727 | - | - | - | 0.750 | 0.977 | - | Mlig455_014082 {REF} {Length: 1503} {Smed: dd_Smed_v6_12908_0_1, dd_Smed_v6_12908_0_1, [Score=52.4, Expect=1e-08]} {RNA1509_50808} {RNA1310_3413} {RNA815_20403} | |
92. | MligTC455_41250 | 104 | 2.16 | Mlig455_010456, Mlig455_010476, Mlig455_061901 | Neo: - Age: - |
1.726 | - | - | 0.749 | - | 0.977 | - | Mlig455_010456 {REF} {Length: 2561} {RNA1310_39237} {RNA815_40339} Mlig455_010476 {REF} {Length: 2776} {RNA1310_39237} {RNA815_40339} Mlig455_061901 {REF} {Length: 2797} {RNA1310_39237} {RNA815_40339} |
|
93. | MligTC455_18607 | 203 | 4.23 | Mlig455_012344, Mlig455_012722 | Neo: - Age: - Region-enriched R2: 3.338/0.02204 |
ANKRD63 | 1.725 | - | - | - | 0.760 | 0.965 | - | Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436} Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436} |
94. | MligTC455_33814 | 559 | 11.65 | Mlig455_061944 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.446/0.00053 |
MOXD1 | 1.725 | - | - | - | 0.753 | 0.972 | - | Mlig455_061944 {REF} {Length: 2816} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.5]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.8]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=129, Expect=2e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=141, Expect=1e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=3e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=9e-32]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=120, Expect=7e-30]} {RNA1509_41983} {RNA1310_8990, RNA1509_41983} {RNA1509_41983, RNA815_3230} |
95. | MligTC455_41512 | 268 | 5.59 | Mlig455_057018 | Neo: - Age: Down-Down-Up |
HMCN2 | 1.723 | - | - | - | 0.772 | 0.951 | - | Mlig455_057018 {REF} {Length: 2115} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=167.2]; Immunoglobulin domain [PF13927.8, score=124.8]; Immunoglobulin domain [PF13895.8, score=78.7]; Immunoglobulin domain [PF00047.27, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=45.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=40.4]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=83.6, Expect=3e-16]; ENSG00000138347, MYPN, myopalladin, [Score=82.8, Expect=4e-16]; ENSG00000129116, PALLD, palladin, cytoskeletal associated protein, [Score=82.4, Expect=4e-16]; ENSG00000072195, SPEG, SPEG complex locus, [Score=82.0, Expect=6e-16]} {Mouse: ENSMUSG00000061462, Obscn, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, [Score=84.7, Expect=8e-17]; ENSMUSG00000058056, Palld, palladin, cytoskeletal associated protein, [Score=81.6, Expect=4e-16]; ENSMUSG00000026207, Speg, SPEG complex locus, [Score=80.9, Expect=9e-16]} {Dmel: FBgn0052311, zormin, [Score=102, Expect=7e-23]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=77.4, Expect=8e-15]} {Smed: dd_Smed_v6_13910_0_1, dd_Smed_v6_13910_0_1, [Score=127, Expect=3e-31]} {RNA1509_44395} {RNA1310_15128.1, RNA1509_44395} {RNA1509_44395, RNA815_29263} |
96. | MligTC455_43664 | 35 | 0.73 | Mlig455_039606 | Neo: - Age: - Region-enriched R4: 6.555/0.01908 |
KY | 1.723 | - | - | - | 0.739 | 0.984 | - | Mlig455_039606 {REF} {Length: 4549} {Pfam: WD domain, G-beta repeat [PF00400.34, score=37.6]} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=113, Expect=4e-25]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=112, Expect=7e-25]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=147, Expect=8e-36]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=142, Expect=1e-35]} {Smed: dd_Smed_v6_8615_0_1, dd_Smed_v6_8615_0_1, [Score=293, Expect=7e-90]} {RNA1509_7582} {RNA1310_2203} {RNA815_6135} |
97. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 1.721 | - | - | - | 0.752 | 0.969 | - | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
98. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 1.718 | - | - | - | 0.745 | 0.973 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
99. | MligTC455_03824 | 55 | 1.15 | Mlig455_050990 | Neo: - Age: Up-Down-Up |
ADRB2 | 1.717 | - | - | - | 0.756 | 0.961 | - | Mlig455_050990 {REF} {Length: 1974} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=273.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=45.6]} {Human: ENSG00000169252, ADRB2, adrenoceptor beta 2, [RH, Score=229, Expect=2e-69]} {Mouse: ENSMUSG00000045730, Adrb2, adrenergic receptor, beta 2, [RH, Score=227, Expect=2e-68]} {Dmel: FBgn0266137, Dop1R2, Dopamine 1-like receptor 2, [RH, Score=295, Expect=9e-91]} {Celegans: WBGene00016872, dop-4, Dopamine receptor 4, [RH, Score=248, Expect=1e-75]} {Smed: dd_Smed_v6_22802_0_1, dd_Smed_v6_22802_0_1, [RH, Score=322, Expect=8e-106]} {RNA1310_48971} |
100. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1.717 | - | - | - | 0.741 | 0.976 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |